| Application number | Title of the application | Filing Date | Status |
|---|
| 10/069197 | AMINOSALICYCLIC ACID AMIDES AND THEIR USE FOR COMBATING ORGANISMS THAT ARE HARMFUL TO PLANTS | Feb 11, 2002 | Abandoned |
Array
(
[id] => 6308073
[patent_doc_number] => 20020094999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer\'s disease and dementias'
[patent_app_type] => new
[patent_app_number] => 10/071488
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8665
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071488 | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias | Feb 6, 2002 | Issued |
Array
(
[id] => 6774677
[patent_doc_number] => 20030018015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Novel compounds and methods for inhibiting/treating HIV infections and AIDS related symptoms'
[patent_app_type] => new
[patent_app_number] => 10/068635
[patent_app_country] => US
[patent_app_date] => 2002-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11092
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068635
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068635 | 2-amino-9H-purin-9-yl compounds and methods for inhibiting/treating HIV infections and AIDS related symptoms | Feb 4, 2002 | Issued |
Array
(
[id] => 6770635
[patent_doc_number] => 20030216575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Novel pyranosyl cytosines: pharmaceutical formulations and methods'
[patent_app_type] => new
[patent_app_number] => 10/067017
[patent_app_country] => US
[patent_app_date] => 2002-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18138
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216575.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067017
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067017 | Pyranosyl cytosines: pharmaceutical formulations and methods | Feb 3, 2002 | Issued |
Array
(
[id] => 6048648
[patent_doc_number] => 20020169146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Pharmaceutically acceptable salts of tricyclic compounds'
[patent_app_type] => new
[patent_app_number] => 10/067096
[patent_app_country] => US
[patent_app_date] => 2002-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10489
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169146.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067096
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067096 | Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds | Feb 3, 2002 | Issued |
Array
(
[id] => 6745715
[patent_doc_number] => 20030022898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Methods of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK)'
[patent_app_type] => new
[patent_app_number] => 10/062847
[patent_app_country] => US
[patent_app_date] => 2002-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25906
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022898.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062847 | Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK) | Jan 31, 2002 | Issued |
Array
(
[id] => 1281393
[patent_doc_number] => 06642180
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Biphenyl-substituted cyclic ketoenols as pesticides'
[patent_app_type] => B1
[patent_app_number] => 10/048764
[patent_app_country] => US
[patent_app_date] => 2002-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24810
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 428
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642180.pdf
[firstpage_image] =>[orig_patent_app_number] => 10048764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/048764 | Biphenyl-substituted cyclic ketoenols as pesticides | Jan 24, 2002 | Issued |
Array
(
[id] => 6278734
[patent_doc_number] => 20020107251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Heterobicyclic derivatives'
[patent_app_type] => new
[patent_app_number] => 10/050855
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64737
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050855
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050855 | Heterobicyclic derivatives | Jan 17, 2002 | Issued |
Array
(
[id] => 6683953
[patent_doc_number] => 20030119817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Oxazolidinone derivatives as potential antimicrobials'
[patent_app_type] => new
[patent_app_number] => 10/051784
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22310
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051784 | Oxazolidinone piperazinyl derivatives as potential antimicrobials | Jan 16, 2002 | Issued |
Array
(
[id] => 6474323
[patent_doc_number] => 20020151556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Method and associated compounds for forming nanotubes'
[patent_app_type] => new
[patent_app_number] => 10/050292
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18186
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050292 | Method and associated pyrimido4,5-dpyrimidine-2,5-diones and pyrido4,3-dpyrimidin-2-ones for forming nanotubes | Jan 15, 2002 | Issued |
Array
(
[id] => 7368043
[patent_doc_number] => 20040092537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/250940
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12169
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092537.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250940 | Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists | Jan 9, 2002 | Issued |
Array
(
[id] => 7306224
[patent_doc_number] => 20040116447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/250952
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18967
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250952 | Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists | Jan 9, 2002 | Issued |
Array
(
[id] => 7468376
[patent_doc_number] => 20040053945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative'
[patent_app_type] => new
[patent_app_number] => 10/470337
[patent_app_country] => US
[patent_app_date] => 2003-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3377
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470337
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470337 | [7-(3-chloro-4-methoxybenzlamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, synthesis thereof and intermediates used therein | Dec 28, 2001 | Issued |
Array
(
[id] => 1308595
[patent_doc_number] => 06617461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-09
[patent_title] => 'Process for preparation of optically active N-substituted azetidine-2-carboxylic acids'
[patent_app_type] => B2
[patent_app_number] => 09/926189
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7051
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617461.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926189
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926189 | Process for preparation of optically active N-substituted azetidine-2-carboxylic acids | Dec 19, 2001 | Issued |
Array
(
[id] => 1096775
[patent_doc_number] => 06822095
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'Method for producing 4,6-dichloropyrimidine'
[patent_app_type] => B1
[patent_app_number] => 10/019093
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1957
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/822/06822095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10019093
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/019093 | Method for producing 4,6-dichloropyrimidine | Dec 18, 2001 | Issued |
Array
(
[id] => 6307993
[patent_doc_number] => 20020094983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Quinazolinone and benzoxazine derivatives as progesterone receptor modulators'
[patent_app_type] => new
[patent_app_number] => 10/023063
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21610
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023063
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023063 | 1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators | Dec 16, 2001 | Issued |
| 10/030744 | Amine-modified pseudomycin compounds | Dec 12, 2001 | Abandoned |
Array
(
[id] => 946633
[patent_doc_number] => 06964967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-15
[patent_title] => 'Substituted pyrido[2,3-d]pyrimidines and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 10/015532
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 48175
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/964/06964967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015532 | Substituted pyrido[2,3-d]pyrimidines and methods for their use | Dec 10, 2001 | Issued |
Array
(
[id] => 1217197
[patent_doc_number] => 06706839
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-16
[patent_title] => 'Chemical partitioning agents and methods of using same'
[patent_app_type] => B1
[patent_app_number] => 09/913231
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6826
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/706/06706839.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913231
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913231 | Chemical partitioning agents and methods of using same | Dec 9, 2001 | Issued |
Array
(
[id] => 1065691
[patent_doc_number] => 06846817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-25
[patent_title] => 'Nicotine receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 09/997718
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17649
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/846/06846817.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997718
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997718 | Nicotine receptor ligands | Nov 29, 2001 | Issued |
